Accounts Payable and Accrued Expenses (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2025

May 31, 2025

Dec. 31, 2024

Accounts Payable and Accrued Expenses (Tables) [Line Items]

Schedule of Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses as of June 30, 2025 and December 31, 2024 consisted of:

		June 30, 2025			December 31, 2024
		(Unaudited)
Research and development expenses payable		$	728,793		$	778,205
Professional fees payable			109,300			127,031
Others			12,657			13,375
		$	850,750		$	918,611

Accounts payable and accrued expenses as of December 31, 2024 and 2023 consisted of:

		December 31, 2024			December 31, 2023
Deferred bonus and salaries payable		$	—		$	451,660
Research and development expenses payable			778,205			1,162,155
Professional fees payable			127,031			175,324
Cost of healthcare services payable			—			61,826
Insurance expenses payable			—			27,463
Others			13,375			15,913
		$	918,611		$	1,894,341

DiamiR Biosciences Corp. [Member]

Accounts Payable and Accrued Expenses (Tables) [Line Items]

Schedule of Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consist of the following:

		May 31, 2025			May 31, 2024
Outside services		$	220,411		$	123,065
Employee compensation			5,884			12,285
Other			5,563			13,298
Total		$	231,858		$	148,648